Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer

被引：194
|
作者：
Winter, Jordan M. [1 ]
Yeo, Charles J. [1 ]
Brody, Jonathan R. [1 ]
机构：
[1] Thomas Jefferson Univ, Dept Surg, Philadelphia, PA 19107 USA
来源：
JOURNAL OF SURGICAL ONCOLOGY | 2013年 / 107卷 / 01期
关键词：
pancreatic cancer; pancreatic ductal adenocarcinoma; biomarkers; predictive markers; prognostic markers; SERUM CA-19-9 LEVELS; GENE-EXPRESSION; ADJUVANT CHEMOTHERAPY; PHOSPHOGLYCERATE KINASE-1; DUCTAL ADENOCARCINOMA; CA19-9; LEVELS; SURVIVAL; GEMCITABINE; RECURRENCE; IDENTIFICATION;
D O I：
10.1002/jso.23192
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Serum CA 19-9 is the only FDA approved biomarker recommended for use in the routine management of pancreatic ductal adenocarcinoma (PDA). Over 2,000 biomarker studies related to pancreatic cancer appear in the literature, highlighting the need to discover and develop improved tests. Diagnostic biomarkers have implications for early detection of PDA, prognostic markers predict patient survival and recurrence patterns, and predictive markers can help personalize treatment regimens. J. Surg. Oncol. 2013;107:1522. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码：15 / 22
页数：8
相关论文
共 50 条
  • [21] Diagnostic, prognostic, and predictive biomarkers in gastric cancer: from conventional to novel biomarkers
    Khalili-Tanha, Ghazaleh
    Khalili-Tanha, Nima
    Rouzbahani, Arian Karimi
    Mahdieh, Ramisa
    Jasemi, Kimia
    Ghaderi, Rosa
    Leylakoohi, Fatemeh Khojasteh
    Ghorbani, Elnaz
    Khazaei, Majid
    Hassanian, Seyed Mahdi
    Gataa, Ibrahim Saeed
    Ferns, Gordon
    Nazari, Elham
    Avan, Amir
    TRANSLATIONAL RESEARCH, 2024, 274 : 35 - 48
  • [22] Diagnostic biomarkers for pancreatic cancer: An update
    Yang, Ming
    Zhang, Chun-Ye
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (45) : 7862 - 7865
  • [23] Diagnostic and Prognostic Biomarkers in Pancreatic Carcinoma
    Liang, John J.
    Kimchi, Eric T.
    Staveley-O'Carroll, Kevin F.
    Tan, Dongfeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2009, 2 (01): : 1 - 10
  • [24] Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal Adenocarcinoma
    Naito, Yoshiki
    Akiba, Jun
    Kinjo, Yoshinao
    Sadashima, Eiji
    Ogata, Toshiro
    Yano, Yuta
    Tanigawa, Masakio
    Nakayama, Masamichi
    Kawahara, Akihiko
    Okabe, Yoshinobu
    Sakai, Hisamune
    Hisaka, Toru
    Akagi, Yoshito
    Yano, Hirohisa
    ANTICANCER RESEARCH, 2022, 42 (08) : 4145 - 4151
  • [25] Advances in biomarkers and techniques for pancreatic cancer diagnosis
    Wu, Haotian
    Ou, Suwen
    Zhang, Hongli
    Huang, Rui
    Yu, Shan
    Zhao, Ming
    Tai, Sheng
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [26] Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer
    Eberly, Haenel W.
    Sciscent, Bao Y.
    Lorenz, F. Jeffrey
    Rettig, Eleni M.
    Goyal, Neerav
    BIOMEDICINES, 2024, 12 (02)
  • [27] Identification of Immune-Related Prognostic Biomarkers in Pancreatic Cancer
    Lin, Xiaoyan
    Ma, Jiakang
    Ren, Kaikai
    Hou, Mingyu
    Zhou, Bo
    Shen, Yong
    Zhang, Ling
    Yuan, Ling
    Ma, Jun
    NANOSCIENCE AND NANOTECHNOLOGY LETTERS, 2020, 12 (12) : 1355 - 1367
  • [28] Prognostic and Predictive Biomarkers in Cancer
    Nair, Meera
    Sandhu, Sardul Singh
    Sharma, Anil K.
    CURRENT CANCER DRUG TARGETS, 2014, 14 (05) : 477 - 504
  • [29] Exosomes as diagnostic and predictive biomarkers in lung cancer
    Reclusa, Pablo
    Taverna, Simona
    Pucci, Marzia
    Durendez, Elena
    Calabuig, Silvia
    Manca, Paolo
    Jose Serrano, Maria
    Sober, Laure
    Pauwels, Patrick
    Russo, Antonio
    Rolfo, Christian
    JOURNAL OF THORACIC DISEASE, 2017, 9 : S1373 - S1382
  • [30] Advances in pancreatic cancer biomarkers
    Hasan, Syed
    Jacob, Rojymon
    Manne, Upender
    Paluri, Ravi
    ONCOLOGY REVIEWS, 2019, 13 (01) : 69 - 76
12345